ALEX ESPANA: Open Payments
NPI 1922721091 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,561 in 152 payments from 21 companies in 2025. Trend: 2023 $2,592 · 2024 $3,297 · 2025 $3,561
Food & beverage: $3,329Education: $232
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $450 |
| Janssen Biotech, Inc. | 11 | $402 |
| Novartis Pharmaceuticals Corporation | 20 | $395 |
| PFIZER INC. | 18 | $312 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $310 |
| GENZYME CORPORATION | 9 | $265 |
| Amgen Inc. | 10 | $257 |
| Galderma Laboratories, L.P. | 9 | $257 |
| UCB, Inc. | 7 | $209 |
| Regeneron Healthcare Solutions, Inc. | 7 | $148 |
Products named: DUPIXENT, TREMFYA, CIBINQO, OTEZLA, NEMLUVIO, RINVOQ, SKYRIZI, Bimzelx.
Industry payments across TX — which companies pay providers there.
